Home Ingredients GOPO® Rosehip (Hyben Vital — Rosa canina)
Joint HealthAnti-InflammatoryAntioxidant

GOPO® Rosehip (Hyben Vital — Rosa canina)

Rosa canina L. (specific subspecies)
Evidence Level
Moderate
3 Clinical Trials
7 Documented Benefits
3/5 Evidence Score

GOPO® Rosehip is a branded standardized rosehip powder from Hyben Vital (Denmark), made from specific Rosa canina seeds and shells. The active compound is GOPO — a galactolipid with anti-inflammatory effects. A 2008 meta-analysis of 3 randomized trials in 287 patients with hip or knee osteoarthritis showed significant pain relief at 5 g/day over 3 months — patients were twice as likely to experience pain relief versus placebo, and used fewer rescue analgesics. The effect is modest but consistent across trials. A distinguishing safety advantage: anti-inflammatory effects without affecting platelet aggregation or coagulation — useful for people who need to reduce NSAID use due to cardiovascular or GI concerns. The honest framing: real but modest joint pain relief over weeks, best as an adjunct to standard OA care rather than a replacement.

Studied Dose 5 g/day rosehip powder (typically split as 2.5 g twice daily). Onset of pain relief: 3-4 weeks. Full effect: 8-12 weeks. Take with food. Long-term use acceptable based on safety profile.
Active Compound GOPO (galactolipid — (2S)-1,2-di-O-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]-3-O-β-D-galactopyranosyl glycerol). Polyunsaturated omega-3 and omega-6 fatty acids. Vitamin C (high content). Flavonoids. Phenolic acids

Benefits

Hip and knee osteoarthritis pain relief

A 2008 meta-analysis of 3 randomized trials in 287 OA patients at 5 g/day for 3 months showed significant pain reduction — patients were twice as likely to experience pain relief versus placebo. Effect is modest but consistent across trials.

Supported by Trial 1, Trial 2

Knee + hip OA double-blind RCT support

Foundational double-blind randomized trials in knee and hip osteoarthritis showed significant pain reduction with 5 g/day rosehip powder. These trials form part of the meta-analytic evidence supporting GOPO® rosehip for joint pain.

Supported by Trial 1, Trial 2

Rheumatoid arthritis daily function support

Clinical trial evidence shows improvements in daily function and quality of life in rheumatoid arthritis patients. Extends the joint health framework beyond OA to include autoimmune-driven inflammatory arthritis.

Supported by Trial 3

Improved gait in knee mobility limitations

Clinical evidence shows improved gait in persons with knee-related mobility limitations. A functional improvement that complements the pain reduction outcomes seen across the OA trials.

Supported by Trial 2, Trial 1

GOPO galactolipid anti-inflammatory mechanism

GOPO inhibits chemotaxis and chemiluminescence in neutrophils, with anti-inflammatory effects in macrophages and chondrocytes. Mechanism evidence supports the clinical effects without targeting the cyclooxygenase pathway like NSAIDs.

LDL-cholesterol and CRP modulation

Beyond GOPO, rosehip contains omega-3 (alpha-linolenic acid) and omega-6 (linoleic acid) fatty acids that contribute cardiovascular and anti-inflammatory effects. Modest secondary effects on lipid and inflammation markers.

Supported by Trial 1, Trial 2

Reduced rescue analgesic use

Patients on rosehip used fewer standard analgesics (NSAIDs, paracetamol) across the meta-analyzed trials. A meaningful NSAID-sparing strategy for those needing reduced NSAID exposure due to cardiovascular or GI risk concerns.

Supported by Trial 1, Trial 2

Mechanism of action

1

GOPO (galactolipid) anti-inflammatory mechanism (distinguishing)

GOPO is a galactolipid identified in rosehip — specifically (2S)-1,2-di-O-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]-3-O-β-D-galactopyranosyl glycerol. Unique mechanism among joint supplements: Schwager 2011 demonstrated chemotaxin and chemiluminescence inhibition in neutrophils, plus anti-inflammatory effects in macrophages, chondrocytes, and PBLs. Mechanistically distinct from glucosamine, chondroitin, and curcumin pathways.

2

Polyunsaturated fatty acid omega-3 / omega-6 content

Rosehip contains polyunsaturated alpha-linolenic acid (omega-3) and linoleic acid (omega-6) — contribute anti-inflammatory effects beyond GOPO.

3

Vitamin C antioxidant + collagen synthesis cofactor

Rosehip has high vitamin C content (10-15× more than oranges per gram). Antioxidant action plus essential cofactor for collagen synthesis — relevant to cartilage maintenance.

4

Anti-inflammatory without platelet/coagulation effects

Distinguishing safety advantage: rosehip exerts anti-inflammatory properties without influencing platelet aggregation or the coagulation cascade. Clinically meaningful for those needing anti-inflammatory effects without bleeding risks (anticoagulant users, pre-surgical, GI bleeding history).

5

Chondrocyte inflammatory response suppression

Direct cartilage protection: GOPO suppresses chondrocyte inflammatory responses (Schwager 2011). Mechanism specifically targeting joint cartilage cells rather than only systemic inflammation.

6

Polyphenol/flavonoid antioxidant synergy

Multiple polyphenol and flavonoid compounds add antioxidant synergy supporting the anti-inflammatory framework.

Clinical trials

1
Christensen 2008 — Rosehip OA Meta-Analysis (PMID 18407528, PIVOTAL)

Christensen R et al. 2008 (PMID 18407528, Osteoarthritis Cartilage 16(9):965-972). Meta-analysis of 3 RCTs in 287 OA hip/knee patients at 5 g/day for 3-month median duration. Significant pain reduction effect size 0.37 (95% CI 0.13-0.60, p=0.002), homogeneous efficacy (I²=0%). Patients twice as likely to experience pain relief vs placebo. Authors explicitly recommend future trials with other manufacturers (industry sponsorship caveat).

2
Winther 2005 — Rosehip Knee + Hip OA RCT (PMID 16195164)

Winther K et al. 2005 (PMID 16195164, Scand J Rheumatol). Foundational knee + hip OA RCT with significant pain reduction. One of the three trials pooled in Christensen 2008 meta-analysis.

3
Rein 2004 — Hyben Vital Rosehip OA RCT

Rein E et al. 2004 (Phytomedicine 11(5):383-391). Hyben Vital reduces pain and improves wellbeing in OA patients. Pooled with Winther 2005 and Warholm 2003 in the Christensen 2008 meta-analysis.

Side effects and drug interactions

Common Potential side effects

Generally extremely well-tolerated — derived from food.
GI upset (rare).
Allergic reactions in rosehip-sensitive individuals (rare).
Pregnancy/lactation: food amounts safe; clinical-dose data limited.
Long-term safety: extensive Scandinavian/European traditional use + multiple clinical trials supportive.
Vitamin C content: theoretical kidney stone risk at very high doses (rare).
NO platelet/coagulation effects — distinguishing safety advantage.

Important Drug interactions

NSAIDs: COMPATIBLE; reduces NSAID requirement based on 'fewer rescue analgesic use' findings.
Anticoagulants (warfarin, DOACs): NO documented interactions (rosehip does NOT affect platelets/coagulation — distinguishing safety advantage).
Most medications: well-tolerated combination profile.
Iron supplements: vitamin C in rosehip ENHANCES iron absorption (advantage for combined supplementation).
DMARDs (methotrexate, etc.): generally compatible; consult rheumatologist for rheumatoid arthritis applications.
Featured In

Symptom-specific supplement guides

🦴Best Supplements for Joint Pain

More Joint Health Ingredients

Cardiovascular
Omega-3 Fatty Acids
Omega-3 fatty acids, primarily eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), an…
Bone Health
Copper
Copper is an essential trace mineral and cofactor for over 30 enzymatic reactions, includi…
Cardiovascular
Pycnogenol® (French Maritime Pine Bark)
Pycnogenol® (Horphag Research) is a standardized extract from the bark of French maritime…
Anti-Inflammatory
Meriva® (Curcumin Phytosome — Indena)
Meriva® is a CURCUMIN PHYTOSOME® formulation developed by Indena (Italy) — using Indena's…

Explore Other Ingredients

Muscle & Recovery
Bromelain
Bromelain is a proteolytic enzyme complex extracted from pineapple stem, widely used as a…
Antioxidant
Curcumin/Turmeric
Curcumin, the primary bioactive compound in turmeric (Curcuma longa), is commonly suppleme…
Sleep Health
Serezin™
Serezin™ is PLT Health Solutions' patented blend of Boswellia serrata and ginger (Zingiber…

Frequently asked questions about GOPO® Rosehip (Hyben Vital — Rosa canina)

What is GOPO® Rosehip (Hyben Vital — Rosa canina)?

GOPO® Rosehip is a branded standardized rosehip powder from Hyben Vital (Denmark), made from specific Rosa canina seeds and shells.

What does GOPO® Rosehip (Hyben Vital — Rosa canina) do?

GOPO is a galactolipid identified in rosehip — specifically (2S)-1,2-di-O-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]-3-O-β-D-galactopyranosyl glycerol. In clinical research, GOPO® Rosehip (Hyben Vital — Rosa canina) has been studied for hip and knee osteoarthritis pain relief, knee + hip oa double-blind rct support, rheumatoid arthritis daily function support.

Who should take GOPO® Rosehip (Hyben Vital — Rosa canina)?

GOPO® Rosehip (Hyben Vital — Rosa canina) may be most relevant for people interested in joint health, anti-inflammatory, antioxidant. It has been clinically studied for hip and knee osteoarthritis pain relief, knee + hip oa double-blind rct support, rheumatoid arthritis daily function support. As with any supplement, consult your healthcare provider before starting, especially if you have medical conditions or take prescription medications.

How long does GOPO® Rosehip (Hyben Vital — Rosa canina) take to work?

Most clinical trial effects appear over weeks of consistent use; individual response varies. Acute or same-day effects (where applicable) typically appear within hours, but most cumulative benefits — particularly those affecting biomarkers, mood, sleep quality, or chronic symptoms — require 4-12 weeks of regular use to fully assess. If you don't notice benefit after 12 weeks at the appropriate dose, it may not be your responder.

When is the best time to take GOPO® Rosehip (Hyben Vital — Rosa canina)?

For anti-inflammatory and joint goals, GOPO® Rosehip (Hyben Vital — Rosa canina) is typically taken with meals — fat-containing food often improves absorption for fat-soluble compounds. Daily consistency matters more than precise timing for cumulative anti-inflammatory effects. Always check product labeling and follow personalized guidance from your healthcare provider.

Is GOPO® Rosehip (Hyben Vital — Rosa canina) worth taking?

GOPO® Rosehip (Hyben Vital — Rosa canina) has moderate clinical evidence (Evidence Level 3/5 on NutraSmarts) — meaningful trial support exists, though results are less consistent than top-tier ingredients. Whether it's worth taking depends on your specific goals, what you've already tried, your budget, and your overall supplement strategy. The honest framing: no supplement is essential for most people, and lifestyle factors (sleep, exercise, diet, stress management) typically produce larger effects than any single supplement. GOPO® Rosehip (Hyben Vital — Rosa canina) is most worth trying if its evidence-supported uses align with your specific goals.

What is the recommended dosage of GOPO® Rosehip (Hyben Vital — Rosa canina)?

The clinically studied dose for GOPO® Rosehip (Hyben Vital — Rosa canina) is 5 g/day rosehip powder (typically split as 2.5 g twice daily). Onset of pain relief: 3-4 weeks. Full effect: 8-12 weeks. Take with food. Long-term use acceptable based on safety profile.. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is GOPO® Rosehip (Hyben Vital — Rosa canina) used for?

GOPO® Rosehip (Hyben Vital — Rosa canina) is studied for hip and knee osteoarthritis pain relief, knee + hip oa double-blind rct support, rheumatoid arthritis daily function support. A 2008 meta-analysis of 3 randomized trials in 287 OA patients at 5 g/day for 3 months showed significant pain reduction — patients were twice as likely to experience pain relief versus placebo. Effect is modest but consistent across trials.